Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.69
-0.55 (-3.86%)
Aug 19, 2026, 2:59 PM EDT - Market open

Surgery Partners Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3663,3093,1142,7432,5392,225
Revenue Growth
3.99%6.24%13.52%8.03%14.12%19.62%
Cost of Revenue
2,6082,5442,3692,0961,9641,734
Gross Profit
757.9765745.6647.5574.9491.4
Selling, General & Admin
121.7118.2138.7120.9102.2104
Other Operating Expenses
-10.2-8.7-20-7.5-19-15.5
Operating Expenses
288.7285.5271.3231.5198187.3
Operating Income
469.2479.5474.3416376.9304.1
Interest Expense
-293.9-272.6-201.7-193-234.9-221
Earnings From Equity Investments
22.322.919.514.212.511.3
Other Non Operating Income (Expenses)
12.5-----
EBT Excluding Unusual Items
210.1229.8292.1237.2154.594.4
Merger & Restructuring Charges
-65.1-73.9-100.1-61.7-47.5-39.8
Gain (Loss) on Sale of Assets
-33.7-30.4-40.6-14.4-11.1-2.2
Legal Settlements
-7.6-7.30.8-10.629.3-
Other Unusual Items
-1.3-1.3-5.1-15.5-14.928.8
Pretax Income
102.4116.9147.1135110.381.2
Income Tax Expense
20.518134.6-0.323.310.5
Earnings From Continuing Operations
81.998.912.5135.38770.7
Minority Interest in Earnings
-170.5-176.8-180.6-147.2-141.6-141.6
Net Income
-88.6-77.9-168.1-11.9-54.6-70.9
Preferred Dividends & Other Adjustments
-----10.3
Net Income to Common
-88.6-77.9-168.1-11.9-54.6-81.2
Net Income Growth
------
Shares Outstanding (Basic)
1281271261269272
Shares Outstanding (Diluted)
1281271261269272
Shares Change
1.28%0.86%0.40%36.61%26.96%48.49%
EPS (Basic)
-0.69-0.61-1.33-0.09-0.59-1.12
EPS (Diluted)
-0.69-0.61-1.33-0.09-0.59-1.12
EPS Growth
------
Free Cash Flow
187.6195.6209.720578.229.5
Free Cash Flow Per Share
1.461.541.661.630.850.41
Gross Margin
22.51%23.12%23.94%23.60%22.64%22.08%
Operating Margin
13.94%14.49%15.23%15.16%14.84%13.67%
Profit Margin
-2.63%-2.35%-5.40%-0.43%-2.15%-3.65%
Free Cash Flow Margin
5.57%5.91%6.73%7.47%3.08%1.33%
EBITDA
646.4655.5626.9534.1491.7402.9
EBITDA Margin
19.20%19.81%20.13%19.47%19.36%18.11%
D&A For EBITDA
177.2176152.6118.1114.898.8
EBIT
469.2479.5474.3416376.9304.1
EBIT Margin
13.94%14.49%15.23%15.16%14.84%13.67%
Effective Tax Rate
20.02%15.40%91.50%-21.12%12.93%
SEC Filings: 10-K · 10-Q